Insider Trading History of Hutt Peter Barton


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hutt Peter Barton since year 2005. The trader's CIK number is 1171527. At the time of the last reporting, Hutt Peter Barton was the Director of Concert Pharmaceuticals, Inc. . (stock ticker symbol CNCE). See this page for all insider trading activities at Concert Pharmaceuticals, Inc. .

Note that in the past HUTT PETER BARTON also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Hutt Peter Barton since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-08-08 CNCE Concert Pharmaceuticals, Inc. Sale 3,539 10.31 36,487
2019-08-08 CNCE Concert Pharmaceuticals, Inc. Option Ex 3,539 4.41 15,606
2016-11-14 CNCE Concert Pharmaceuticals, Inc. Option Ex 22,123 1.13 24,998
2016-11-14 CNCE Concert Pharmaceuticals, Inc. Sale 22,123 9.81 217,026
2016-08-29 BIND Bind Therapeutics, Inc Option Ex 15,000 .44 6,600
2014-07-14 [NONE] Q Therapeutics, Inc. Option Ex 32,451 .15 4,867
2014-09-12 MNTA Momenta Pharmaceuticals Inc Sale 3,640 11.42 41,568
2010-12-10 MNTA Momenta Pharmaceuticals Inc Sale 62,498 14.67 916,845
2010-12-14 MNTA Momenta Pharmaceuticals Inc Option Ex 64,000 .23 14,784
2010-12-14 MNTA Momenta Pharmaceuticals Inc Sale 64,000 14.35 918,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hutt Peter Barton (Director of Concert Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.